Eric Adams
Vermögen: 2 988 $ am 30.09.2026
Vermögen: 2 988 $ am 30.09.2026
Mr. Eric A. Adams is a President, Chief Executive Officer & Director at InMed Pharmaceuticals, Inc. He is on the Board of Directors at InMed Pharmaceuticals, Inc. Mr. Adams was previously employed as a Chief Executive Officer by Ronin8 Technologies Ltd., a Non-Executive Director by enGene, Inc., a Director-Oncology Marketing by QLT, Inc., a Senior Manager-Business Development by Abbott Laboratories, and a Country Manager by Fresenius SE.
He received his undergraduate degree from the University of Southern Indiana and a graduate degree from the University of South Carolina.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.12.2025 | 2’197 ( 0.04% ) | 2 988 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Vorstandsvorsitzender | 16.06.2016 |
| Unternehmen | Position | Ende |
|---|---|---|
Ronin8 Technologies Ltd.
Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Operates a materials recovery facility | Vorstandsvorsitzender | 01.02.2015 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Vorstandsvorsitzender | 01.07.2013 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Vertrieb & Marketing | 01.12.2002 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01.08.1996 |
| FRESENIUS SE & CO. KGAA | Corporate Officer/Principal | 01.06.1992 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Hospital/Nursing ManagementHealth Services Develops and manufactures generic drugs, biopharmaceuticals, infusion & nutrition therapies and medical devices | Health Services |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
InMed Pharmaceuticals, Inc.
InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Health Technology |
University of South Carolina
University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern Indiana
University of Southern Indiana Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ronin8 Technologies Ltd.
Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Operates a materials recovery facility | Industrial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen